We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
-15.88%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$4.48B
AUM Growth
+$2.15B
Cap. Flow
+$2.99B
Cap. Flow %
66.91%
Top 10 Hldgs %
76.84%
Holding
89
New
19
Increased
22
Reduced
9
Closed
13

Top Buys

Rank Stock Value
1
BUFF
Blue Buffalo Pet Products, Inc
BUFF
+$2.82B
2
BLUE
bluebird bio
BLUE
+$16.2M
3
YUM icon
Yum! Brands
YUM
+$12.6M
4
MS icon
Morgan Stanley
MS
+$9.1M
5
AGIO icon
Agios Pharmaceuticals
AGIO
+$6.35M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$32.9M
2
MBLY
Mobileye N.V.
MBLY
+$26.6M
3
AER icon
AerCap
AER
+$17.2M
4
AAL icon
American Airlines Group
AAL
+$16M
5
BABA icon
Alibaba
BABA
+$14.5M

Sector Composition

Rank Sector Weight
1 Consumer Staples 46.01%
2 Healthcare 19.71%
3 Consumer Discretionary 5.21%
4 Financials 1.51%
5 Communication Services 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EEM icon
51
CALL
iShares MSCI Emerging Markets ETF
EEM
$27.5B
$8.2M 0.18%
+250,000
New +$8.83M
MS icon
52
Morgan Stanley
MS
$319B
$7.88M 0.18%
+250,000
New +$9.1M
MCRB icon
53
Seres Therapeutics
MCRB
$45M
$5.93M 0.13%
10,000
+1,997
+25% +$1.63M
CCXI
54
DELISTED
ChemoCentryx, Inc.
CCXI
$5.45M 0.12%
900,000
– –
JMEI
55
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$4.93M 0.11%
50,000
– –
HAPN
56
CALL
Happen Inc
HAPN
$2.14B
$4.3M 0.1%
65,000
+15,000
+30% +$1.02M
BLUE
57
CALL
DELISTED
bluebird bio
BLUE
$4.28M 0.1%
+3,860
New +$7.04M
RXDX
58
DELISTED
Ignyta, Inc.
RXDX
$4.17M 0.09%
475,000
+25,000
+6% +$358K
IONS icon
59
CALL
Ionis Pharmaceuticals
IONS
$8.93B
$4.04M 0.09%
+100,000
New +$5.18M
ALNY icon
60
CALL
Alnylam Pharmaceuticals
ALNY
$38.3B
$4.02M 0.09%
+50,000
New +$5.56M
CLDX icon
61
Celldex Therapeutics
CLDX
$2.94B
$3.95M 0.09%
25,000
+8,333
+50% +$2.36M
LCTX icon
62
Lineage Cell Therapeutics
LCTX
$264M
$3.85M 0.09%
1,588,475
– –
CLLS
63
Cellectis
CLLS
$288M
$3.29M 0.07%
125,000
– –
RGNX icon
64
Regenxbio
RGNX
$616M
$2.59M 0.06%
+117,400
New +$3M
AGEN
65
Agenus
AGEN
$276M
$2.53M 0.06%
28,023
+1,015
+4% +$150K
HLT icon
66
Hilton Worldwide
HLT
$72.4B
$2.29M 0.05%
33,333
-150,000
-82% -$11.6M
IRWD icon
67
Ironwood Pharmaceuticals
IRWD
$586M
$2.26M 0.05%
258,954
– –
IBRX icon
68
ImmunityBio
IBRX
$7.15B
$2.01M 0.04%
+175,000
New +$3.82M
PARN
69
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$1.72M 0.04%
500,000
– –
HLI icon
70
Houlihan Lokey
HLI
$9.72B
$1.64M 0.04%
+75,000
New +$1.64M
JMEI
71
CALL
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$1.48M 0.03%
+15,000
New +$2.2M
ARRY
72
CALL
DELISTED
Array Biopharma Inc
ARRY
$1.37M 0.03%
300,000
– –
SPNC
73
DELISTED
Spectranetics Corp
SPNC
$1.18M 0.03%
+100,000
New +$1.79M
CERE
74
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$1.11M 0.02%
1,024,020
– –
XOMA
75
CALL
DELISTED
Xoma
XOMA
$301K 0.01%
20,000
– –
1 2
3
4

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q3 2015 Portfolio in Review

As of Q3 2015, Artal Group held 89 positions worth $4.48B, up 93% from $2.32B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Artal Group deployed $2.99B of net new capital in Q3 2015, opening 19 new positions and adding to 22 existing holdings. Its largest new stake was Blue Buffalo Pet Products, Inc: 114,987,547 shares worth $2.06B.

By sector, the portfolio is most concentrated in Consumer Staples at 46% of assets, up from 0% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $14.5M trimmed.

  • Artal Group's largest Q3 2015 buy was Blue Buffalo Pet Products, Inc: 114,987,547 shares worth $2.06B.
  • Artal Group added most to bluebird bio in Q3 2015, an estimated $16.2M increase.
  • Artal Group's biggest Q3 2015 reduction was Alibaba, cutting an estimated $14.5M.
  • Artal Group fully exited Amazon in Q3 2015, selling an estimated $32.9M.
  • Artal Group's ten largest holdings make up 77% of its $4.48B portfolio in Q3 2015.
  • Artal Group opened 19 new positions and closed 13 in Q3 2015.
  • Artal Group's portfolio value rose 93% quarter-over-quarter to $4.48B.

Based on Artal Group's 13F filing for Q3 2015, filed 13 Nov 2015.